Home >> Clinical Trial Guidance >> Ongoing Clinical Trials
Home >> Clinical Trial Guidance >> Ongoing Clinical Trials
We inform you of the clinical trials that are being conducted by K-MASTER Precision Medicine Project Group.
We inform you of the clinical trials that are being conducted by K-MASTER Precision Medicine Project Group.
* Protocol No. | KM-10(B) | |||
---|---|---|---|---|
* Research Title | Open label, multicenter, prospective phase II study to investigate the efficacy and safety of Trastuzumab biosimilar plus treatment of physician’s choice in Patients with HER-2 Positive Metastatic Breast Cancer Who Progressed after 2 or more HER-2 ... | |||
* Overall Research Director | Park In-Hye | Affiliate | National Cancer Center | |
Carcinoma | Metastatic breast cancer | |||
Target Gene | HER2 | Clinical Trial Drug | Trastuzumab+ Selected anti-cancer drugs | |
Research period | 2018.12.01 ~ 2021.12.31 | Progress Status | registering | |
Number of recipients | 21 / 119 | Registration rate | 17.65% |
Institutional research participation
No. | Research manager | Research institution |
---|
:: There is no registered research participant information. ::
If you want to participate in the clinical examination, please contact the email address below.
Email kmaster@korea.ac.kr | CONTACT Secretariat 02.2286.1564 | Clinical Trial Coordinating Center 02.2286.1562